Literature DB >> 8053488

Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse.

V L Godfrey1, B T Rouse, J E Wilkinson.   

Abstract

The X-linked mutation, scurfy (sf), causes a fatal lymphoreticular disease characterized by runting, lymphadenopathy, splenomegaly, hypergammaglobulinemia, exfoliative dermatitis, Coombs'-positive anemia, and death by 24 days of age. T lymphocytes are required to mediate this syndrome as shown by a total absence of disease in mice bred to be scurfy and nude (sf/Y; nu/nu). The scurfy phenotype is not transmitted by sf/Y bone marrow transplants, though cells of scurfy origin do reconstitute all lymphoid organs in the recipient mouse. These data suggest that scurfy disease results from an abnormal T cell development process and not from an intrinsic stem cell defect. We therefore tested the ability of transplanted scurfy thymuses to transmit scurfy disease to congenic euthymic mice, to athymic (nude) mice, and to severe combined immunodeficiency (SCID) mice. Euthymic recipients of sf/Y thymic grafts remained clinically normal as did all SCID and nude recipients of normal thymus transplants. Morphological lesions similar to those found in scurfy mice occurred in all H-2-compatible nude and SCID recipients of sf/Y thymic grafts. Intraperitoneal injections of scurfy thymocytes, splenocytes, and lymph node cells also transmitted the scurfy phenotype to H-2-compatible nude mice and SCID mice. Our findings indicate that scurfy disease can be transmitted to T cell-deficient mice by engraftment of scurfy T cells, but that pathogenic scurfy T cell activities can be inhibited (or prevented) in immunocompetent recipient mice.

Entities:  

Mesh:

Year:  1994        PMID: 8053488      PMCID: PMC1887402     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease.

Authors:  M L Eigenbrodt; E H Eigenbrodt; D L Thiele
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

2.  Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education.

Authors:  V L Godfrey; J E Wilkinson; E M Rinchik; L B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease.

Authors:  J Ferrara; F J Guillen; B Sleckman; S J Burakoff; G F Murphy
Journal:  J Invest Dermatol       Date:  1986-04       Impact factor: 8.551

4.  Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice.

Authors:  C L Sidman; J D Marshall; H Von Boehmer
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

5.  Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns.

Authors:  M R Charley; J L Bangert; B L Hamilton; J N Gilliam; R D Sontheimer
Journal:  J Invest Dermatol       Date:  1983-11       Impact factor: 8.551

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  Selection of the T cell receptor repertoire in Lpr mice.

Authors:  L R Herron; R A Eisenberg; E Roper; V N Kakkanaiah; P L Cohen; B L Kotzin
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

8.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus.

Authors:  K Matsumoto; Y Yoshikai; T Asano; K Himeno; A Iwasaki; K Nomoto
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

Review 10.  Association of lpr gene with graft-vs.-host disease-like syndrome.

Authors:  A N Theofilopoulos; R S Balderas; Y Gozes; M T Aguado; L M Hang; P R Morrow; F J Dixon
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  23 in total

1.  Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

Authors:  Chong Chen; Yu Liu; Yang Liu; Pan Zheng
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse.

Authors:  D D Patel
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Molecular orchestration of differentiation and function of regulatory T cells.

Authors:  Li-Fan Lu; Alexander Rudensky
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

4.  FoxP3: a life beyond regulatory T cells.

Authors:  Yang Liu; Pan Zheng
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 5.  TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Development of thymically derived natural regulatory T cells.

Authors:  Matthew L Bettini; Dario A A Vignali
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 7.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes.

Authors:  S K Smyk-Pearson; A C Bakke; P K Held; R S Wildin
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 10.  Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells.

Authors:  Pan Zheng; Xing Chang; Qianjin Lu; Yang Liu
Journal:  J Autoimmun       Date:  2013-02-01       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.